Healthcare ❯Pharmaceuticals ❯Vaccines

RSV Vaccine

Moderna Moderna's mRESVIA Moderna mResvia Competitor Comparison Efficacy and Safety Duration of Protection

Moderna Reports Unexpected Profit on Strong COVID Vaccine Sales

Cost-cutting measures and robust demand for its COVID vaccine have propelled Moderna to a surprising third-quarter profit.

FDA Approves Moderna's mRNA RSV Vaccine for Older Adults